Latest Share Chat

REMOVE ADS

Glaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,851.50 31.00 (1.70%)

Bid:

1,851.50

Ask:

1,852.00

Spread: 0.50 (0.027%)

Market Cap: £74.25b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

GSK publishes provisional 2025 dividend dates

11 Nov 2024 15:01

RNS Number : 7596L

GSK PLC

11 November 2024

GSK plc

GSK publishes provisional dividend dates

GSK announces the following dividend dates for 2025:

These dates are indicative and may be subject to change.

Results	Announcement date	Ordinary Shares Ex-dividend date	American Depositary Shares Ex-dividend date	Record date	Last date for DRIP elections	Payable
Q1 2025	Wednesday 30 April 2025	Thursday 15 May 2025	Friday 16 May 2025	Friday 16 May 2025	Thursday 19 June 2025	Thursday 10 July 2025
Q2 2025	Wednesday 30 July 2025	Thursday 14 August 2025	Friday 15 August 2025	Friday 15 August 2025	Thursday 18 September 2025	Thursday 9 October 2025
Q3 2025	Wednesday 29 October 2025	Thursday 13 November 2025	Friday 14 November 2025	Friday 14 November 2025	Monday 15 December 2025	Thursday 8 January 2026
Q4 2025	Wednesday 4 February 2026	Thursday 19 February 2026	Friday 20 February 2026	Friday 20 February 2026	Tuesday 17 March 2026	Thursday 9 April 2026

V A Whyte

Company Secretary

11 November 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCQKDBPQBDDPDD

Date		Source	Headline
1st Jun 2026	3:00 pm	RNS	Total Voting Rights
1st Jun 2026	3:00 pm	RNS	Transaction in Own Shares
28th May 2026	9:30 am	RNS	Positive Phase 3 data for bepirovirsen
27th May 2026	3:30 pm	RNS	Director/PDMR Shareholding
26th May 2026	3:00 pm	RNS	Admission to Trading
26th May 2026	3:00 pm	RNS	Transaction in Own Shares
22nd May 2026	10:30 am	RNS	Q2 2026 Results Date Confirmed - 28 July 2026
20th May 2026	3:30 pm	RNS	Director/PDMR Shareholding
19th May 2026	3:30 pm	RNS	Director/PDMR Shareholding
18th May 2026	3:00 pm	RNS	Transaction in Own Shares
18th May 2026	7:00 am	RNS	Japan MHLW approves Arexvy for adults 18-49 AIR
14th May 2026	3:30 pm	RNS	Director/PDMR Shareholding
11th May 2026	3:30 pm	RNS	Director/PDMR Shareholding
11th May 2026	7:05 am	RNS	Collaboration with CTTQ for bepirovirsen
11th May 2026	7:00 am	RNS	GSK - final tranche of share buyback programme
6th May 2026	6:22 pm	RNS	Result of AGM
5th May 2026	3:30 pm	RNS	Director/PDMR Shareholding
1st May 2026	3:00 pm	RNS	Holding(s) in Company
1st May 2026	3:00 pm	RNS	Total Voting Rights
29th Apr 2026	3:30 pm	RNS	Director/PDMR Shareholding
29th Apr 2026	7:00 am	RNS	1st Quarter Results
28th Apr 2026	3:30 pm	RNS	Director/PDMR Shareholding
28th Apr 2026	7:00 am	RNS	Bepirovirsen priority review US filing acceptance
27th Apr 2026	12:00 pm	RNS	Efimosfermin granted US/EU regulatory designations
27th Apr 2026	7:00 am	RNS	TESARO update on AnaptysBio Inc. litigation
24th Apr 2026	3:30 pm	RNS	Director/PDMR Shareholding
23rd Apr 2026	7:00 am	RNS	Transaction in Own Shares
22nd Apr 2026	7:00 am	RNS	Transaction in Own Shares
21st Apr 2026	7:00 am	RNS	Transaction in Own Shares
20th Apr 2026	3:30 pm	RNS	Director/PDMR Shareholding
20th Apr 2026	7:00 am	RNS	Blenrep approved in China for 2L+ multiple myeloma
20th Apr 2026	7:00 am	RNS	Transaction in Own Shares
17th Apr 2026	7:00 am	RNS	Transaction in Own Shares
16th Apr 2026	3:30 pm	RNS	Director/PDMR Shareholding
16th Apr 2026	7:00 am	RNS	Transaction in Own Shares
15th Apr 2026	7:12 am	RNS	GSK completes acquisition of 35Pharma Inc.
15th Apr 2026	7:00 am	RNS	Transaction in Own Shares
14th Apr 2026	3:30 pm	RNS	Director/PDMR Shareholding
14th Apr 2026	7:00 am	RNS	Transaction in Own Shares
13th Apr 2026	3:30 pm	RNS	Director/PDMR Shareholding
13th Apr 2026	7:00 am	RNS	Transaction in Own Shares
13th Apr 2026	7:00 am	RNS	GSK presents positive data for BEHOLD 1 B7 H4 ADC
10th Apr 2026	3:30 pm	RNS	Director/PDMR Shareholding
10th Apr 2026	7:00 am	RNS	Transaction in Own Shares
9th Apr 2026	3:30 pm	RNS	Director/PDMR Shareholding
9th Apr 2026	7:00 am	RNS	Transaction in Own Shares
8th Apr 2026	7:00 am	RNS	Exdensur approved for CRSwNP in China
8th Apr 2026	7:00 am	RNS	Transaction in Own Shares
7th Apr 2026	7:00 am	RNS	Transaction in Own Shares
2nd Apr 2026	7:00 am	RNS	Transaction in Own Shares

Latest Share Chat

Glaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Intraday Glaxosmithkline Share Chart

GSK publishes provisional 2025 dividend dates

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending